These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9826768)

  • 1. Highly efficient cellular uptake of c-myb antisense oligonucleotides through specifically designed polymeric nanospheres.
    Tondelli L; Ricca A; Laus M; Lelli M; Citro G
    Nucleic Acids Res; 1998 Dec; 26(23):5425-31. PubMed ID: 9826768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specifically designed polymeric nanospheres increase cellular uptake of unmodified antisense ODNs.
    Tondelli L; Laus M; Ricca A; Citro G
    Nucleosides Nucleotides; 1999; 18(6-7):1677-9. PubMed ID: 10474244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.
    Gryaznov S; Skorski T; Cucco C; Nieborowska-Skorska M; Chiu CY; Lloyd D; Chen JK; Koziolkiewicz M; Calabretta B
    Nucleic Acids Res; 1996 Apr; 24(8):1508-14. PubMed ID: 8628685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin receptor-targeted transfer peptides for efficient delivery of antisense oligodeoxynucleotides.
    Bachmann AS; Surovoy A; Jung G; Moelling K
    J Mol Med (Berl); 1998 Feb; 76(2):126-32. PubMed ID: 9500678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.
    Del Bufalo D; Cucco C; Leonetti C; Citro G; D'Agnano I; Benassi M; Geiser T; Zon G; Calabretta B; Zupi G
    Br J Cancer; 1996 Aug; 74(3):387-93. PubMed ID: 8695353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells.
    Citro G; Szczylik C; Ginobbi P; Zupi G; Calabretta B
    Br J Cancer; 1994 Mar; 69(3):463-7. PubMed ID: 8123474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of an anti-c-myb antisense oligonucleotide on myo-intimal proliferation. Specificity of action and consequences on vasoreactivity].
    Castier Y; Chemla E; Chardigny C; Nierat J; Eudes D; Vasseur MA; Bruneval P; Carpentier A; Fabiani JN
    Arch Mal Coeur Vaiss; 1996 Jul; 89(7):889-96. PubMed ID: 8869251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.
    Anfossi G; Gewirtz AM; Calabretta B
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3379-83. PubMed ID: 2541445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of c-myb antisense oligonucleotide to prevent intimal hyperplasia is nonspecific.
    Castier Y; Chemla E; Nierat J; Heudes D; Vasseur MA; Rajnoch C; Bruneval P; Carpentier A; Fabiani JN
    J Cardiovasc Surg (Torino); 1998 Feb; 39(1):1-7. PubMed ID: 9537527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: implications for the treatment of Burkitt's lymphoma.
    Williams SA; Gillan ER; Knoppel E; Buzby JS; Suen Y; Cairo MS
    Ann Oncol; 1997; 8 Suppl 1():25-30. PubMed ID: 9187425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailor-made core-shell nanospheres for antisense oligonucleotide delivery: IV. Adsorption/release behaviour.
    Tondelli L; Canto E; Pistagna A; Butt S; Tripiciano A; Cortesi R; Sparnacci K; Laus M
    J Biomater Sci Polym Ed; 2001; 12(12):1339-57. PubMed ID: 11922479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core-shell nanospheres for oligonucleotide delivery. V: adsorption/release behavior of 'stealth' nanospheres.
    Tondelli L; Ballestri M; Magnani L; Vivarelli D; Fini A; Cerasi A; Chiarantini L; Sparnacci K; Laus M
    J Biomater Sci Polym Ed; 2003; 14(11):1209-27. PubMed ID: 14768909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of c-myb and c-fes antisense oligodeoxynucleotides on granulocytic differentiation of human myeloid leukemia HL60 cells.
    Ferrari S; Donelli A; Manfredini R; Sarti M; Roncaglia R; Tagliafico E; Rossi E; Torelli G; Torelli U
    Cell Growth Differ; 1990 Nov; 1(11):543-8. PubMed ID: 2088479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
    Normand N; Valamanesh F; Savoldelli M; Mascarelli F; BenEzra D; Courtois Y; Behar-Cohen F
    Mol Vis; 2005 Mar; 11():184-91. PubMed ID: 15761390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of the 5-lipoxygenase gene by c-myb overexpression in differentiated HL-60 cells.
    Ponton A; Thirion JP; Sirois P
    Prostaglandins; 1997 Jan; 53(1):49-58. PubMed ID: 9068066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment.
    Brignole C; Pagnan G; Marimpietri D; Cosimo E; Allen TM; Ponzoni M; Pastorino F
    Cancer Lett; 2003 Jul; 197(1-2):231-5. PubMed ID: 12880987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A DNA uptake-stimulating protein increases the antiproliferative effect of c-myb antisense oligonucleotide on leukemic cells.
    Tóth G; Schlammadinger J; Aradi J; Antal-Szalmás P; Sipka S; Balázs M; Kovács P; Fehér Z; Falus A
    Cell Biol Int; 2004; 28(11):817-23. PubMed ID: 15563404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
    J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides.
    Szczylik C; Skórski T; Malaguarnera L; Hetman J; Chen ST; Calabretta B
    Folia Histochem Cytobiol; 1996; 34(3-4):129-34. PubMed ID: 8967957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
    Williams SA; Chang L; Buzby JS; Suen Y; Cairo MS
    Leukemia; 1996 Dec; 10(12):1980-9. PubMed ID: 8946941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.